PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of westjmedLink to Publisher's site
 
West J Med. 1980 April; 132(4): 294–300.
PMCID: PMC1272065

Clinical Value of Teichoic Acid Antibody Titers in the Diagnosis and Management of the Staphylococcemias

Abstract

Differentiation of endocarditic from nonendocarditic Staphylococcus aureus (SA) septicemia is prognostically and therapeutically important. A study of 68 cases of either SA or streptococcal sepsis, including 50 cases of SA sepsis of both cardiac and noncardiac origin, was done to determine the presence and titer of serum teichoic acid antibodies (TAA's) by double immunodiffusion. Thirty-seven uninfected controls were also examined. There was no statistical difference in either incidence or peak TAA titers in endocardial versus deepseated, extracardiac SA sepsis. However, in both of these groups, incidence and peak titers were significantly higher than in intravascular catheter-related SA sepsis, streptococcal endocarditis and controls (P<0.05). Peak TAA titers in SA sepsis develop on admission or shortly thereafter (6 to 11 days) and permit early decisions on degree of tissue infection, likelihood of metastatic seeding and necessity for higher-dose, longer-term antibiotic therapy.

Cases of catheter-related SA sepsis with no clinical evidence of metastatic SA seeding and with negative or low-titered (1:1) TAA's were classified as superficial sepsis. Treatment consisted of short-term, low-dose antistaphylococcal regimens and catheter removal. In posttherapy follow-up after 6 to 12 weeks, all of the patients were cured and no signs of endocarditis or deepseated SA infection developed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Nolan CM, Beaty HN. Staphylococcus aureus bacteremia. Current clinical patterns. Am J Med. 1976 Apr;60(4):495–500. [PubMed]
  • Infectious disease emergencies. Part II: patients presenting with cardiac decompensation or circulatory insufficiency (shock). West J Med. 1976 Aug;125(2):119–136. [PMC free article] [PubMed]
  • Nagel JG, Tuazon CU, Cardella TA, Sheagren JN. Teichoic acid serologic diagnosis of staphylococcal endocarditis. Use of gel diffusion and counterimmunoelectrophoretic methods. Ann Intern Med. 1975 Jan;82(1):13–17. [PubMed]
  • Tuazon CU, Sheagren JN. Teichoic acid antibodies in the diagnosis of serious infections with Staphylococcus aureus. Ann Intern Med. 1976 May;84(5):543–546. [PubMed]
  • Bayer AS, Theofilopoulos AN, Tillman DB, Dixon FJ, Guze LB. Use of circulating immune complex levels in the serodifferentiation of endocarditic and nonendocarditic septicemias. Am J Med. 1979 Jan;66(1):58–62. [PubMed]
  • Bayer AS, Theofilopoulos AN, Eisenberg R, Dixon FJ, Guze LB. Circulating immune complexes in infective endocarditis. N Engl J Med. 1976 Dec 30;295(27):1500–1505. [PubMed]
  • Churchill MA, Jr, Geraci JE, Hunder GG. Musculoskeletal manifestations of bacterial endocarditis. Ann Intern Med. 1977 Dec;87(6):754–759. [PubMed]
  • Thorley JD, Jones SR, Sanford JP. Perinephric abscess. Medicine (Baltimore) 1974 Nov;53(6):441–451. [PubMed]
  • Crowder JG, White A. Teichoic acid antibodies in staphylococcal and nonstaphylococcal endocarditis. Ann Intern Med. 1972 Jul;77(1):87–90. [PubMed]
  • Fedorko J, Fossieck BE, Jr, Parker RH. Counterimmunoelectrophoresis of staphylococcal antibody. J Clin Microbiol. 1976 Jun;3(6):599–603. [PMC free article] [PubMed]
  • Nagel JG, Sheagren JN, Tuazon CU, Cardella TA. Teichoic acids in pathogenic Staphylococcus aureus. J Clin Microbiol. 1977 Sep;6(3):233–237. [PMC free article] [PubMed]
  • Bayer AS, Guze LB. Staphylococcus aureus bacteremic syndromes: diagnostic and therapeutic update. Dis Mon. 1979 Jun;25(9):1–42. [PubMed]
  • Watanakunakorn C, Tan JS, Phair JP. Some salient features of Staphylococcus aureus endocarditis. Am J Med. 1973 Apr;54(4):473–481. [PubMed]
  • Tuazon CU, Sheagren JN, Choa MS, Marcus D, Curtin JA. Staphylococcus aureus bacteremia: relationship between formation of antibodies to teichoic acid and development of metastatic abscesses. J Infect Dis. 1978 Jan;137(1):57–62. [PubMed]
  • Iannini PB, Crossley K. Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann Intern Med. 1976 May;84(5):558–560. [PubMed]
  • WILSON R, HAMBURGER M. Fifteen years' experience with staphylococcus septicemia in a large city hospital; analysis of fifty-five cases in the Cincinnati General Hospital 1940 to 1954. Am J Med. 1957 Mar;22(3):437–457. [PubMed]
  • Nolan CM, Abernathy RS. Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia. Arch Intern Med. 1977 Aug;137(8):997–1000. [PubMed]
  • Riley HD., Jr Vancomycin and novobiocin. Med Clin North Am. 1970 Sep;54(5):1277–1289. [PubMed]
  • Larinkari UM, Valtonen MV, Sarvas M, Valtonen VV. Teichoic acid antibody test: its use in patients with coagulase-positive staphylococcal bacteremia. Arch Intern Med. 1977 Nov;137(11):1522–1525. [PubMed]
  • Jackson LJ, Sottile MI, Aguilar-Torres FG, Dee TH, Rytel MW. Correlation of antistaphylococcal antibody titers with severity of staphylococcal disease. Am J Med. 1978 Apr;64(4):629–633. [PubMed]

Articles from The Western Journal of Medicine are provided here courtesy of BMJ Group